|
2022
|
Invention
|
Lipid crystalline compositions with enhanced stability for topical delivery of active agent combi... |
|
2021
|
Invention
|
Inhibition of covid-19 virus by multiple-component formulations. The treatment of human subjects ... |
|
|
Invention
|
Inhibition of dyrk1a kinase. Novel compounds which inhibit DYRK1A activity comprise thymoquinone ... |
|
|
Invention
|
Combination anti-cancer products and methods. Combination dosage forms of anti-cancer products in... |
|
|
Invention
|
Low-temperature synthesis of thymoquinone and harmaline compounds. Low-temperature syntheses of t... |
|
2020
|
Invention
|
Method of treatment of actinic keratoses. Novel medicaments for the treatment of actinic keratose... |
|
|
Invention
|
Fused polycyclic dimers. Novel fused tricyclic or bicyclic dimers, such as β-carboline and quinol... |
|
|
Invention
|
Therapeutic agents and uses thereof. Human therapeutic compositions are provided, comprising comp... |
|
|
Invention
|
Topical medicaments. Topical medicaments for the treatment of mammalian skin are provided, which ... |
|
2019
|
Invention
|
Thymoquinone/harmaline and related reaction products. New compositions of matter useful for the t... |
